Effect of nonselective and selective opioid receptors antagonists on antinociceptive action of acetaminophen [Part III]

Polish Journal of Pharmacology

Volumn 56, Issue 5, 2004, Pages 539-545

  Bujalska, Magdalena ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Acetaminophen; Antinociception; Opiodergic systems

Indexed keywords

DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTRIBEN; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; PARACETAMOL; SIGMA OPIATE RECEPTOR;

ANALGESIC ACTIVITY; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG MEGADOSE; EXPERIMENTAL ANIMAL; MALE; MECHANICAL STIMULATION; NONHUMAN; PAIN THRESHOLD; RAT; RAT STRAIN; STATISTICAL ANALYSIS;

ACETAMINOPHEN; ANALGESIA; ANALGESICS; ANIMALS; MALE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; RATS; RATS, WISTAR; RECEPTORS, OPIOID;

EID: 12344317982     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bartolome JV, Chang KJ, Bartolome MB: The inhibition of ornithine decarboxylase activity in developing rat tissues by central nervous system beta-endorphin is mediated by mi-opioid receptors, but not by delta- or epsilon-opioid receptors. Eur J Pharmacol, 1995, 284, 43-50.
2. Bianchi M, Panerai AE: The dose-related effects of paracetamol on hyperalgesia and nociception in the rat. Br J Pharmacol, 1996, 117, 130-132.
3. Björkman R: Central antinociceptive effects of nonsteroidal anti-inflammatory drugs and paracetamol. Acta Anaesthesiol Scand, 1995, 39, Suppl 103, 1-44.
4. Bujalska M: Effect of cyclooxygenase and NO synthase inhibitors administered centrally on antinociceptive action of acetaminophen (Part II). Pol J Pharmacol, 2003, 55, 1001-1011.
5. Bujalska M, Gumułka WS: Effect of cyclooxygenase and NO synthase inhibitors on antinociceptive action of acetaminophen. Pol J Pharmacol, 2001, 53, 341-350.
6. Carlsson KH, Jurna I: Central analgesic effect of paracetamol manifested by depression of nociceptive activity in thalamic neurones of the rat. Neurosci Lett, 1987, 77, 339-343.
7. Carlsson KH, Monzel W, Jurna I: Depression by morphine and the non-opioid analgesic agents, metamiol (dipyrone), lysine acetylsalicylate and paracetamol, of activity in rat thalamus neurones evoked by electrical stimulation of nociceptive afferents. Pain, 1988, 32, 313-326.
8. Clissold SP: Paracetamol and phenacetin. Drugs, 1986, 32, Suppl 4, 46-59.
9. Day RO, Graham GG, Whelton A: The position of paracetamol in the world of analgesics. Am J Ther, 2000, 7, 51-54.
10. Flether D, Benoist JM, Gautron M, Guibaud G: Isobolographic analysis of interactions between intravenous morphine, propacetamol and diclofenac in carrageenin-injected rats. Anesthesiology, 1997, 87, 317-326.
11. Hylden JLK, Wilcox GL: Intrathecal morphine in mice: a new technique. Eur J Pharmacol, 1980, 67, 313-316.
12. Jensen TS: Opioids in the brain: supraspinal mechanism in pain control. Acta Anaesthesiol Scand, 1997, 41, 123-132.
13. Kayser V: Endogenous opioid systems in the modulation of pain: behavioral studies in rat models of persistent hyperalgesia. Proceedings of the World Congress on Pain, Progress in Pain Reserch and Management, Vol. 2, Ed. Gebhart GF, Hammond DL, Jensen TS, IASP Press, Seattle, 1994.
14. Meredith TJ, Goulding R: Paracetamol. Postgrad Med J, 1980, 56, 459-473.
15. Molke Jensen F, Dahl JB, Frigast C: Direct spinal effect of intrathecal acetaminophen on visceral noxious stimulation in rabits. Acta Anaesthesiol Scand, 1992, 36, 837-841.
16. Noble EP, Wurtman RJ: A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain. Life Sci, 1967, 6, 281-291.
17. Ohsawa M, Mizoguchi H, Narita M, Chu M, Nagase H, Tseng LF: Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther, 2000, 294, 1106-1111.
18. 3 receptors: in vivo and in vitro evidence. J Pharmacol Exp Ther, 1996, 278, 8-14.
19. 3 receptors. Neuroreport, 1995, 6, 1546-1548.
20. Pini LA, Vitale G, Ottani A, Sandrini M: Naloxone-reversible antinociception by paracetamol in the rat. J Pharmacol Exp Ther, 1997, 280, 2, 934-940.
21. Prescott LF: Paracetamol: past, present, and future. Am J Ther, 2000, 7, 143-147.
22. Randall LO, Selitto JJ: A method for measurement of analgesic activity of inflammed tissue. Arch Int Pharmacodyn Ther, 1957, 111, 409-415.
23. Robinson CA, Hangegeveld CA, De Balbian Vester F: Improved polyethylene cannulation techniques. Physiol Behav, 1969, 4, 123-124.
24. Sandrini M, Romualdi P, Capobianco A, Vitale G, Morelli G, Pini LA, Candeletti S: The effect of paracetamol on nociception and dynorphin A levels in the rat brain. Neuropeptides, 2001, 35, 110-116.
25. Sandrini M, Romualdi P, Vitale G, Morelli G, Capobianco A, Pini LA, Candeletti S: The effect of a paracetamol and morphine combination on dynorphin A levels in the rat brain. Biochem Pharmacol, 2001, 61, 1409-1416.
26. Sandrini M, Vitale G, Ottani A, Pini LA: The potentiation of analgesic activity of paracetamol plus morphine involves the serotoninergic system in rat brain. Inflamm Res, 1999, 48, 120-127.
27. Schwab JM, Schluesener HJ, Laufer S: COX-3: just another COX or the solitary elusive target of paracetamol? Lancet, 2003, 361, 981-982.
28. Stachura Z, Herman ZS: Pharmacological interaction between neuropeptides and morphine or pentazocine in rat spinal cord. Pol J Pharmacol, 1991, 43, 459-469.
29. Stewart PE, Hammond DL: Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic [D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4] deltorphin. J Pharmacol Exp Ther, 1993, 266, 820-828.
30. Strada SJ, Sanders-Bush E, Sulser F: p-Chloramphetamine, temporal relationship between psychomotor stimulation and metabolism of brain norepinephrine. Biochem Pharmacol, 1970, 19, 2621-2629.
31. Tallarida RJ, Murray RB: Manual of Pharmacologic Calculation with Computer Programs. 2nd edn., Springer Verlag, New York, 1986, 131-139.
32. Tjölsen A, Lund A, Hole K: Antinociceptive effect of paracetamol in rats is partially dependent on spinal serotoninergic systems. Eur J Pharmacol, 1991, 193, 193-201.
33. Tseng LF, Collins KA: The tail-flick inhibition induced by β-endorphin administered intrathecally is mediated by ativation of κ- and μ-opioid receptors in the mouse. Eur J Pharmacol, 1992, 214, 59-65.
34. Tseng LF, Tsai JH, Collins KA, Portoghese PS: Spinal delta-2, but not delta 1-, mi-, or kappa-opioid receptors are involved in the tail-flick inhibition induced by beta-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat. Eur J Pharmacol, 1995, 277, 251-256.
35. Vaughan CW, Ingram SL, Connor MA, Christie MJ: How opioids inhibit GABA-mediated neurotransmission? Nature, 1997, 390, 611-614.